Use access key #2 to skip to page content.
$65.00 -1.25 (-1.89%)
10/10/2008 4:00 PM

ImClone Systems, Inc. (IMCL)

CAPS Rating:
**

A biopharmaceutical company which advances oncology care by developing and commercializing a portfolio of targeted biologic treatments designed to address the medical needs of patients with a variety of cancers.

View All Commentary (IMCL)

Recs

0

Avatar jonnywad (73.58) Submitted: 12/14/06 7:59 PM : Outperform Start Price: $28.60 IMCL Score: 165.31

Martha says buy

Report this Post Replies: 0 | Reply

Featured Broker Partners